ARCHIVES

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 15 No. 01 | January 6, 1989

Download PDF Visit The Full Archive

Related Articles

FDA Approves Afinitor For pNET; No Word On Sutent For Same Use

May 6, 2011

Congress Passes NIH Reauthorization.

December 15, 2006

HHS Agency Says It Has No Jurisdiction And No Cause to Act on I-ELCAP Allegations

March 2, 2012

Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events

June 28, 2013

NCI Advisory Group, Other Cancer Meetings

March 31, 1989

NCI Clinical Research Too Similar To Work By Extramural Community, Report Finds

July 21, 1995